Mazdutide
A Study of IBI362 in Participants With Obesity or Overweight
Innovent · Phase 3 · Completed · Enrollment 610
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | Obesity or overweight | n/r | 4 | n/r | n/r |
| IBI362 4 mg | Obesity or overweight | 4 mg | 4 | n/r | n/r |
| IBI362 6 mg | Obesity or overweight | 6 mg | 4 | n/r | n/r |